Javascript must be enabled to continue!
P-TEFb as A Promising Therapeutic Target
View through CrossRef
The positive transcription elongation factor b (P-TEFb) was first identified as a general factor that stimulates transcription elongation by RNA polymerase II (RNAPII), but soon afterwards it turned out to be an essential cellular co-factor of human immunodeficiency virus (HIV) transcription mediated by viral Tat proteins. Studies on the mechanisms of Tat-dependent HIV transcription have led to radical advances in our knowledge regarding the mechanism of eukaryotic transcription, including the discoveries that P-TEFb-mediated elongation control of cellular transcription is a main regulatory step of gene expression in eukaryotes, and deregulation of P-TEFb activity plays critical roles in many human diseases and conditions in addition to HIV/AIDS. P-TEFb is now recognized as an attractive and promising therapeutic target for inflammation/autoimmune diseases, cardiac hypertrophy, cancer, infectious diseases, etc. In this review article, I will summarize our knowledge about basic P-TEFb functions, the regulatory mechanism of P-TEFb-dependent transcription, P-TEFb’s involvement in biological processes and diseases, and current approaches to manipulating P-TEFb functions for the treatment of these diseases.
Title: P-TEFb as A Promising Therapeutic Target
Description:
The positive transcription elongation factor b (P-TEFb) was first identified as a general factor that stimulates transcription elongation by RNA polymerase II (RNAPII), but soon afterwards it turned out to be an essential cellular co-factor of human immunodeficiency virus (HIV) transcription mediated by viral Tat proteins.
Studies on the mechanisms of Tat-dependent HIV transcription have led to radical advances in our knowledge regarding the mechanism of eukaryotic transcription, including the discoveries that P-TEFb-mediated elongation control of cellular transcription is a main regulatory step of gene expression in eukaryotes, and deregulation of P-TEFb activity plays critical roles in many human diseases and conditions in addition to HIV/AIDS.
P-TEFb is now recognized as an attractive and promising therapeutic target for inflammation/autoimmune diseases, cardiac hypertrophy, cancer, infectious diseases, etc.
In this review article, I will summarize our knowledge about basic P-TEFb functions, the regulatory mechanism of P-TEFb-dependent transcription, P-TEFb’s involvement in biological processes and diseases, and current approaches to manipulating P-TEFb functions for the treatment of these diseases.
Related Results
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
P-TEFb is a key regulator of the process controlling the processivity of RNA polymerase II and possesses a kinase activity that can phosphorylate the carboxy-terminal domain of the...
A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites
A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites
Abstract
HIV-1 transcription is tightly regulated: silent in long-term latency and highly active in acutely-infected cells. Transcription is activated by the viral protei...
P-TEFb is degraded by Siah1/2 in quiescent cells
P-TEFb is degraded by Siah1/2 in quiescent cells
Abstract
P-TEFb, composed of CycT1 and CDK9, regulates the elongation of transcription by RNA polymerase II. In proliferating cells, it is regulated by 7SK snRNA in...
Tat gets the "green" light on transcription initiation
Tat gets the "green" light on transcription initiation
Abstract
Human immunodeficiency virus type 1 (HIV-1) Tat transactivation is an essential step in the viral life cycle. Over the past several years, it has become widely a...
In Silico Analysis of miR-223 and miR-181b and Their Target Genes in the Pathogenesis of Acute Promyelocytic Leukaemia
In Silico Analysis of miR-223 and miR-181b and Their Target Genes in the Pathogenesis of Acute Promyelocytic Leukaemia
Acute promyelocytic leukaemia (APL) is the M3 subtype of acute myeloid leukaemia (AML). The hallmark for APL diagnosis is the reciprocal chromosomal translocation between chromosom...
A Three-Dimensional Target Depth-Resolution Method with a Single-Vector Sensor
A Three-Dimensional Target Depth-Resolution Method with a Single-Vector Sensor
This paper mainly studies and verifies the target number category-resolution method in multi-target cases and the target depth-resolution method of aerial targets. Firstly, target ...
Chemical Probe Discovery for DEAD-box RNA Binding Protein DDX21 using Small Molecule Microarrays
Chemical Probe Discovery for DEAD-box RNA Binding Protein DDX21 using Small Molecule Microarrays
Abstract
The DEAD-box family of ATPases plays a critical role in nearly all stages of RNA metabolism, from transcription to degradation, and serves as a major regul...
CRISPR/Cas “non-target” sites inhibit on-target cutting rates
CRISPR/Cas “non-target” sites inhibit on-target cutting rates
Abstract
CRISPR/Cas systems have become ubiquitous for genome editing in eukaryotic as well as bacterial systems. Cas9 associated with a guide RNA (gRNA) searches D...

